Back to Press

Medelinked is the First Application to Feature in BioClinica's App xChange

Published on 15th September 2015 by Medelinked

Patient and consumer-centred engagement technology extends eHealth clinical trial platform

Oxfordshire, 15th September, 2015 - Medelinked, the online health platform that empowers healthcare engagement and management, has announced that it will be the first application featured in the BioClinica®, eHealth App xChange™, an alliance channel for disruptive technology innovation across life sciences and healthcare.

Medelinked allows individuals to use mobile technology and the cloud to increase the effectiveness of health care by enabling them to securely build their health profile online and to connect and share with their network of trusted health partners.

Pennsylvania-based BioClinica, a global specialty clinical trials technology and services provider that serves more than 400 pharmaceutical, biotechnology, and device organizations, recently launched the eHealth App xChange. It provides healthcare payers, providers, researchers, regulators and patients with access to transformative applications integrated with and delivered through BioClinica’s eHealth Cloud™.

Leading innovation in regulated clinical trials

BioClinica eClinical President, Mukhtar Ahmed says: "Our App xChange is an incubator and growth engine for niche technology providers and individual app developers, so we welcome Medelinked as the first in a series of new partners as BioClinica continues to lead industry innovation within the regulated clinical trial space."

Ahmed continues: "Medelinked’s presence in the App xChange will enable research communities to ensure unique levels of patient and consumer engagement so accelerating pre- and post-approval research while creating efficiency and quality benefits."

Driving the global shift in how patients and the healthcare industry connect

Ian Gallifant, Medelinked founder and CEO, says: "With this latest development, Medelinked is further driving the global shift in how patients and the healthcare industry connect from early clinical research and trials right through to day-to-day health management. The fact that BioClinica has chosen Medelinked to be the first to feature on its new strategic and disruptive platform is a profound endorsement of the quality and effectiveness of Medelinked’s technology."

About Medelinked

Leveraging mobile technology and the cloud, Medelinked technology aims to increase health care effectiveness.

Medelinked Health Cloud and API is the leading platform already powering some of the best mHealth applications allowing developers to create a series of new applications that deliver real health benefits to the end user and healthcare professionals.

Using Medelinked individuals are able to create a health profile online that is secure and connect and share their health record with their network of trusted health partners and providers (including doctors, dentists, physiotherapists, trainers, insurers, clinical researchers).

Managing all health data in one place helps individuals securely track, monitor and improve their health state, ensuring their latest health data is accessed and enabling the provision of best possible care, keeping individuals in control of their own health.

Based in Oxfordshire, United Kingdom, Medelinked was founded in 2005.

For more information, please visit

About BioClinica, Inc.

BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company offers industry-leading medical imaging services, enterprise eClinical technologies, patient recruitment and retention, clinical research centers and cardiovascular safety solutions that bring quality and efficiency to every phase of clinical development.

BioClinica's experience spans three decades and includes thousands of studies in all therapeutic areas. The company serves more than 400 pharmaceutical, biotechnology, and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia.

For more information, please visit

Further Information

Ian Gallifant
07879 994944
[email protected]

Jonathan Simnett
07976 227224
[email protected]

Back to Press